SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
Wong, Deysi Viviana Tenazoa, Ribeiro-Filho, Helder Veras, Wanderley, Carlos Wagner Souza, Leite, Caio Abner Vitorino Gonçalves, Lima, Jonilson Berlink, Assef, Alexia Nathália Brígido, Cajado, AurileneJournal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-019-03844-z
Date:
April, 2019
File:
PDF, 1.05 MB
2019
File converter
More search results
More benefits 
